CHAPTER 11 Haemodialysis Practices

CHAPTER 11 Haemodialysis Practices

Tan Chwee ChoonShahnaz Shah Firdaus Khan

Rafidah AbdullahNorleen Bt Zulkarnain Sim

Source: 20th MDTR Report 2012, NRR

CHAPTER 11 Haemodialysis Practices

Tan Chwee ChoonShahnaz Shah Firdaus Khan

Rafidah AbdullahNorleen Bt Zulkarnain Sim

Table 11.1.1: Vascular access on haemodialysis, 1997-2012


Access types1997 1998 1999 2000 2001 2002

n % n % n % n % n % n %Wrist AVF 1427 85 1763 84 2406 81 3559 82 4049 79 4680 78

BCF* 213 13 273 13 431 15 655 15 897 17 1068 18BBF 0 0 0 0 0 0 0 0 0 0 0 0Graft 17 1 26 1 42 1 42 1 83 2 92 2HD Catheter 24 1 45 2 94 3 96 2 115 2 181 3TOTAL 1681 100 2107 100 2973 100 4352 100 5144 100 6021 100

Access types2003 2004 2005 2006 2007

n % n % n % n % n %Wrist AVF 5249 73 5891 75 6405 69 7798 67 8309 64BCF* 1359 21 1693 20 2169 23 2856 25 3421 27BBF 0 0 0 0 0 0 0 0 0 0Graft 136 2 190 2 251 3 306 3 341 3HD Catheter 240 4 332 3 484 5 640 6 843 7TOTAL 6984 100 8106 100 9309 100 11600 100 12914 100

Access types2008 2009 2010 2011 2012

n % n % n % n % n %Wrist AVF 9483 62 10665 60 11130 57 12569 56 13574 53BCF* 4400 29 5243 29 6105 31 7360 33 8741 34BBF 70 1 133 1 191 1 306 1 395 2Graft 479 3 465 3 495 3 489 2 505 2HD Catheter 984 6 1363 8 1513 8 1938 9 2322 9TOTAL 15416 100 17869 100 19434 100 22662 100 25537 100

Table 11.1.2: Difficulties report with vascular access, 1997-2012

Access difficulty1997 1998 1999 2000 2001 2002

n % n % n % n % n % n %Difficulty with needle placement 55 47.4 82 4.2 133 5.4 146 3.9 217 4.5 215 3.9Difficulty in obtaining desired blood flow rate 48 41.4 60 3.1 112 4.6 136 3.7 239 5 235 4.2

Other difficulties 12 10.3 30 1.5 55 2.2 32 0.9 39 0.8 57 1No difficulties 1 0.9 1778 91.2 2155 87.8 3402 91.6 4276 89.6 5073 90.9TOTAL 116 100 1950 100 2455 100 3716 100 4771 100 5580 100

Access difficulty2003 2004 2005 2006 2007

n % n % n % n % n %Difficulty with needle placement 217 3.4 255 3.3 319 3.5 394 3.5 478 3.8Difficulty in obtaining desired blood flow rate 243 4 301 3.7 354 3.9 356 3.1 368 2.9

Other difficulties 60 0.9 67 0.9 58 0.6 45 0.4 57 0.5No difficulties 5970 91.8 6957 92 8339 91.9 10592 93 11577 92.8TOTAL 6490 100 7580 100 9070 100 11387 100 12480 100

Access difficulty2008 2009 2010 2011 2012

n % n % n % n % n %Difficulty with needle placement 417 2.8 522 3 555 2.9 479 2.1 635 2.5Difficulty in obtaining desired blood flow rate 420 2.8 473 2.7 437 2.3 495 2.2 584 2.3

Other difficulties 81 0.5 101 0.6 78 0.4 72 0.3 118 0.5No difficulties 14065 93.9 16482 93.8 18071 94.4 21284 95.3 23983 94.7TOTAL 14983 100 17578 100 19141 100 22330 100 25320 100


Table 11.1.3: Complications reported with vascular access, 1997-2012


Table 11.2.1: Blood flow rates in HD centers, 1997-2012

Blood flow rates(ml/min)

1997 1998 1999 2000 2001 2002

n % n % n % n % n % n %

<150 2 0.1 4 0.2 6 0.2 9 0.2 7 0.1 9 0.2150-199 34 2.1 36 1.7 65 2.3 85 2 69 1.4 69 1.2200-249 649 40.2 735 35.5 962 33.3 1282 30.4 1233 24.5 973 16.7250-299 734 45.5 968 46.7 1367 47.4 1938 45.9 2229 44.3 2692 46.1300-349 176 10.9 298 14.4 455 15.8 812 19.2 1276 25.4 1590 27.2>=350 18 1.1 30 1.4 31 1.1 94 2.2 216 4.3 505 8.7Total 1613 100 2071 100 2886 100 4220 100 5030 100 5838 100Blood flow rates(ml/min)

2003 2004 2005 2006 2007

n % n % n % n % n %

<150 4 0.1 11 0.1 7 0.1 5 0 10 0.1150-199 84 1.1 86 1.2 94 1 103 0.9 87 0.7200-249 882 11.2 879 13 814 9.1 923 8.2 929 7.4250-299 2865 39.8 3112 42.3 3523 39.2 3818 33.8 3821 30.5300-349 2241 34.7 2711 33.1 3226 35.9 4529 40.1 5214 41.7>=350 690 13 1020 10.2 1328 14.8 1920 17 2451 19.6Total 6766 100 7819 100 8992 100 11298 100 12512 100Blood flow rates(ml/min)

2008 2009 2010 2011 2012

n % n % n % n % n %

<150 10 0.1 14 0.1 16 0.1 14 0.1 15 0.1150-199 120 0.8 126 0.7 113 0.6 122 0.6 122 0.5200-249 928 6.2 1178 6.8 1192 6.3 1333 6 1296 5.2250-299 4630 31.1 5050 29 5021 26.5 5520 25 5957 23.8300-349 6126 41.1 7093 40.7 7721 40.8 8936 40.4 10377 41.4>=350 3094 20.8 3977 22.8 4850 25.6 6172 27.9 7294 29.1Total 14908 100 17438 100 18913 100 22097 100 25061 100

Figure 11.2.1: Blood flow rates in HD centers, 1997-2012

0

10

20

30

40

50

%

'97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12

Year

<150 ml/min 150-199 ml/min 200-249 ml/min

250-299 ml/min 300-349 ml/min >=350 ml/min


Table 11.2.2: Number of HD sessions per week, 1997-2012

HD sessions per week

1997 1998 1999 2000 2001 2002

n % n % n n n % n % n %

1 1 0.1 1 0 4 0.1 8 0.2 8 0.2 10 0.22 6 0.4 5 0.2 153 5.1 341 7.9 337 6.5 369 6.23 1664 99 2110 99.6 2811 94.6 3980 91.7 4761 92.3 5603 93.44 9 0.5 2 0.1 3 0.1 10 0.2 50 1 18 0.3Total 1680 100 2118 100 2971 100 4339 100 5156 100 6000 100HD sessions per week

2003 2004 2005 2006 2007

n % n % n % n % n %

1 15 0.1 11 0.2 7 0.1 25 0.2 14 0.12 343 3.5 281 4.9 265 2.8 273 2.3 256 23 6585 96 7742 94.7 9010 96.7 11326 97.2 12602 97.74 9 0.4 30 0.1 31 0.3 34 0.3 31 0.2Total 6952 100 8064 100 9313 100 11658 100 12903 100

HD sessions per week

2008 2009 2010 2011 2012

n % n % n % n % n %

1 5 0 6 0 9 0 6 0 32 0.12 259 1.7 269 1.5 309 1.6 242 1.1 351 1.43 15043 97.9 17574 98 19089 98.1 22474 98.8 25247 98.14 61 0.4 88 0.5 47 0.2 31 0.1 109 0.4Total 15368 100 17937 100 19454 100 22753 100 25739 100


Table 11.2.3: Duration of HD, 1997-2012Duration of HDper session (hours)

1997 1998 1999 2000 2001 2002

n % n % n % n % n % n %

<=3 7 0.4 19 0.9 4 0.1 10 0.2 8 0.2 18 0.33.5 1 0.1 2 0.1 9 0.3 12 0.3 12 0.2 15 0.34 1598 95 1997 94.4 2738 92.2 4086 93.9 4988 96.7 5854 97.74.5 67 4 87 4.1 157 5.3 154 3.5 93 1.8 60 15 8 0.5 8 0.4 61 2.1 75 1.7 59 1.1 47 0.85 1 0.1 3 0.1 0 0 13 0.3 0 0 0 0TOTAL 1682 100 2116 100 2969 100 4350 100 5160 100 5994 100Duration of HDper session (hours)

2003 2004 2005 2006 2007

n % n % n % n % n %

<=3 14 0.3 25 0.2 31 0.3 28 0.2 37 0.33.5 3 0.1 11 0 9 0.1 6 0.1 11 0.14 6798 97.6 7876 97.9 9174 98.5 11507 98.8 12792 99.24.5 66 1.3 106 1 46 0.5 66 0.6 23 0.25 63 0.6 45 0.9 52 0.6 42 0.4 31 0.2>5 0 0 3 0 0 0 1 0 1 0TOTAL 6944 100 8066 100 9312 100 11650 100 12895 100Duration of HDper session (hours)

2008 2009 2010 2011 2012

n % n % n % n % n %

<=3 54 0.4 66 0.4 77 0.4 71 0.3 120 0.53.5 10 0.1 25 0.1 36 0.2 10 0 75 0.34 15189 98.8 17732 98.8 19231 98.8 22588 99.3 25429 98.84.5 74 0.5 78 0.4 72 0.4 40 0.2 72 0.35 42 0.3 42 0.2 50 0.3 39 0.2 43 0.2>5 0 0 1 0 0 0 5 0 3 0TOTAL 15369 100 17944 100 19466 100 22753 100 25742 100

Table 11.2.4: Dialyser membrane types in HD centres, 1997-2012

Dialyser membrane1997 1998 1999 2000 2001 2002

n % n % n % n % n % n %Modified Cellulose 361 21.3 413 19.3 1224 40.9 1611 36.7 1666 37 1377 24.2Regenerated Cellulose 1149 67.8 1201 56.1 1017 33.9 1188 27.1 890 19.8 1474 26Hydrophobic/Hypdrophilic 184 10.9 524 24.5 754 25.2 1589 36.2 1944 43.2 2828 49.8Hydrophilized copolymers 1 0.1 2 0.1 1 0 0 0 0 0 1 0TOTAL 1695 100 2140 100 2996 100 4388 100 4500 100 5680 100

Dialyser membrane2003 2004 2005 2006 2007

n % n % n % n % n %Modified Cellulose 1150 22.1 1719 17.4 1974 21.8 2489 21.6 2890 22.7Regenerated Cellulose 1599 14.8 1150 24.1 930 10.2 997 8.7 699 5.5Hydrophobic/Hypdrophilic 3841 62.2 4846 58 6020 66.3 7860 68.3 8984 70.7Hydrophilized copolymers 35 1 74 0.5 150 1.7 161 1.4 137 1.1TOTAL 6625 100 7789 100 9074 100 11507 100 12710 100

Dialyser membrane2008 2009 2010 2011 2012

n % n % n % n % n %Modified Cellulose 3431 22.7 3241 19 3306 18.9 3928 24.1 3978 26.1Regenerated Cellulose 486 3.2 418 2.5 202 1.2 60 0.4 10 0.1Hydrophobic/Hypdrophilic 10886 72.1 13052 76.6 13609 77.7 12005 73.6 10970 72Hydrophilized copolymers 286 1.9 335 2 409 2.3 323 2 274 1.8TOTAL 15089 100 17046 100 17526 100 16316 100 15232 100


Figure 11.2.4: Dialyser membrane types in HD centres, 1997-2012

0

10

20

30

40

50

60

70

80

90

100

Per

cent

(%

)

1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012Year

Modified Cellulose Regenerated Cellulose

Hydrophobic/Hypdrophilic Hydrophilized copolymers


Table 11.2.5: Frequency of Dialyser use in HD centres, 1997-2012


Table 11.2.6(a): Distribution of prescribed Kt/V, HD patients 1997-2012

Year Number of patients Mean SD Median LQ UQ % patients ≥ 1.3

1997 1558 1.4 0.3 1.4 1.2 1.6 571998 2022 1.4 0.3 1.4 1.2 1.6 651999 2831 1.5 0.4 1.5 1.3 1.7 732000 4085 1.5 0.4 1.5 1.3 1.7 732001 4908 1.5 0.4 1.5 1.3 1.8 742002 5496 1.5 0.4 1.5 1.3 1.7 732003 6525 1.6 0.4 1.6 1.3 1.8 792004 7457 1.6 0.4 1.6 1.4 1.8 822005 8749 1.6 0.4 1.6 1.4 1.9 812006 11092 1.6 0.4 1.6 1.3 1.8 782007 12354 1.6 0.4 1.6 1.3 1.9 782008 14752 1.6 0.4 1.6 1.3 1.8 802009 17252 1.7 0.4 1.6 1.4 1.9 832010 18726 1.6 0.4 1.6 1.4 1.9 812011 21928 1.7 0.4 1.6 1.4 1.9 832012 24930 1.7 0.4 1.7 1.4 1.9 84


Figure 11.2.6(a): Cumulative distribution of prescribed Kt/V, HD patients 1997-2012


0

.25

.5

.75

1

Cum

ulat

ive

dist

ribu

tion

1 1.2 1.4 1.6 1.8 2 2.2 2.4KT/V

1997 2000 20042008 2012

Table 11.2.6(b): Distribution of delivered Kt/V, HD patients 2006-2012

Year Number of patients Mean SD Median LQ UQ % patients ≥1.2 % patients ≥1.3 Variance*

2006 5555 1.4 1.3 1.4 1.2 1.6 76 60 0.1

2007 6360 1.5 0.6 1.4 1.2 1.6 78 62 0.1

2008 8529 1.4 0.3 1.4 1.2 1.6 78 61 0.1

2009 10467 1.5 0.7 1.4 1.2 1.7 81 65 0.1

2010 11697 1.4 0.5 1.4 1.2 1.6 79 63 0.1

2011 13622 1.5 1.2 1.4 1.2 1.6 80 64 0.1

2012 15800 1.5 0.5 1.5 1.3 1.7 82 67 0.1


Figure 11.2.6 (b): Cumulative distribution of delivered Kt/V, HD patients 2006-2012


0

.25

.5

.75

1

Cum

ulat

ive

dist

ribu

tion

.8 1 1.2 1.4 1.6 1.8 2 2.2KT/V

2006 20082010 2012

Table 11.2.6(c): Distribution of URR, HD patients 2006-2012

Year Number of patients Mean SD Median LQ UQ % patients ≥ 65%

2006 8267 71.4 9.2 71.8 66.3 77.1 79

2007 9945 71.3 9.2 71.9 66.3 77.2 79

2008 12601 71.2 9 71.7 66.2 77 79

2009 14947 71 9 71.7 66.1 76.9 79

2010 16727 71.1 8.6 71.6 66.3 76.8 80

2011 19668 71.1 8.8 71.8 66.1 76.9 79

2012 22837 71 9 71.7 66 77 79


Figure 11.2.6 (c): Cumulative distribution of URR, HD patients 2006-2012


0

.25

.5

.75

1

Cum

ulat

ive

dist

ribu

tion

55 60 65 70 75 80 85 90URR

2006 2008 2010 2012

Table 11.2.7(a): Variation in median blood flow rates in HD patients, HD centres, 1997-2012

Year Number of centers Min 5th Centile LQ Median UQ 95th

Centile Max

1997 45 200 200 220 250 250 280 3001998 46 200 200 230 250 250 300 3001999 67 200 200 230 250 250 300 3002000 100 200 200 240 250 275 300 3002001 116 200 220 250 252.5 300 300 3502002 137 200 230 250 280 300 300 3502003 155 200 240 250 280 300 325 3502004 184 220 250 257.5 287.5 300 350 4002005 228 200 250 260 300 300 350 4002006 283 200 250 270 300 300 350 4002007 302 200 250 280 300 300 350 4002008 355 200 250 280 300 300 350 4002009 404 180 250 280 300 320 350 4002010 435 150 250 280 300 320 350 4002011 500 200 250 300 300 330 350 4002012 556 165 250 300 300 350 350 400


Figure 11.2.7 (a): Variation in median blood flow rates in HD patients among centres 2012


100

150

200

250

300

350

400

Blo

od fl

ow r

ate,

ml/m

in

0 50 100 150 200 250 300 350 400 450 500 550Centre

(lower quartile, upper quartile)Median blood flow rate

Table 11.2.7 (b) Proportion of patients with blood flow rates > 300 ml/min, HD centres 1997-2012

Year Number of centers Min 5th Centile LQ Median UQ 95th Centile Max

1997 45 0 0 1 8 19 43 521998 46 0 0 2 11.5 23 61 801999 67 0 0 2 13 30 54 1002000 100 0 0 3 14 38.5 69 812001 116 0 0 8 25.5 51.5 81 1002002 137 0 0 13 33 61 90 1002003 155 0 0 21 45 69 91 1002004 184 0 4 23.5 48.5 73 93 1002005 228 0 0 28 53 77 94 1002006 283 0 5 30 63 83 94 1002007 302 0 7 37 68 84 96 1002008 355 0 9 40 70 86 99 1002009 404 0 11 42.5 72 88 99 1002010 435 0 9 46 75 90 100 1002011 500 0 12.5 55 77 90 100 1002012 556 0 19 57 80 91 100 100


Figure 11.2.7 (b): Variation in Proportion of patients with blood flow rates >= 300 ml/min among HD centres 2012.


0

10

20

30

40

50

60

70

80

90

100

% p

atie

nts

0 50 100 150 200 250 300 350 400 450 500 550Centre

(lower 95% CI, upper 95% CI)% with blood flow rate >=300 ml/min

Table 11.2.7 (c): Proportion of patients with 3 HD sessions per week, HD centres 1997-2012

YearNumber of

centersMin 5th Centile LQ Median UQ 95th Centile Max

1997 47 80 92 99 100 100 100 1001998 46 80 98 100 100 100 100 1001999 69 17 45 97 100 100 100 1002000 100 25 44.5 90.5 100 100 100 1002001 118 23 50 92 100 100 100 1002002 137 28 48 94 99 100 100 1002003 160 36 55 97 100 100 100 1002004 188 37 70 98 100 100 100 1002005 231 40 75 99 100 100 100 1002006 287 52 83 98 100 100 100 1002007 309 51 87 98 100 100 100 1002008 358 51 89 98 100 100 100 1002009 404 18 88 100 100 100 100 1002010 437 20 90 100 100 100 100 1002011 502 50 93 100 100 100 100 1002012 562 17 90 98 100 100 100 100


Figure 11.2.7 (c): Variation in proportion of patients with 3 HD sessions per week among HD centres 2012


0

10

20

30

40

50

60

70

80

90

100

% p

atie

nts

0 50 100 150 200 250 300 350 400 450 500 550Centre

(lower 95% CI, upper 95% CI)% with 3 HD sessions per week

Table 11.2.7 (d): Median prescribed Kt/V in HD patients, HD centres 1997-2012

YearNumber of

centersMin 5th Centile LQ Median UQ 95th Centile Max

1997 44 1.2 1.2 1.3 1.4 1.4 1.5 1.71998 45 1 1.3 1.3 1.4 1.5 1.5 1.61999 67 1.1 1.3 1.4 1.5 1.6 1.8 1.82000 99 1 1.3 1.4 1.5 1.6 1.8 2.82001 114 1.2 1.3 1.4 1.5 1.6 1.7 1.92002 132 1.2 1.3 1.4 1.5 1.6 1.7 1.82003 150 1.1 1.3 1.4 1.6 1.7 1.9 22004 181 1.2 1.4 1.5 1.6 1.7 1.9 2.22005 224 1.2 1.3 1.5 1.6 1.7 1.8 22006 281 1 1.3 1.4 1.6 1.7 1.8 2.12007 302 1.1 1.3 1.4 1.6 1.7 1.8 2.22008 353 1.1 1.3 1.5 1.6 1.7 1.9 2.12009 400 1.1 1.3 1.5 1.6 1.7 1.9 2.22010 434 0.8 1.3 1.5 1.6 1.7 1.9 2.92011 500 1.1 1.3 1.5 1.6 1.8 2 2.52012 555 1.1 1.4 1.5 1.6 1.8 2 2.8


Figure 11.2.7 (d): Variation in median prescribed Kt/V in HD patients among HD centres 2012


1

1.5

2

2.5

3

3.5

KT

/V

0 50 100 150 200 250 300 350 400 450 500 550Centre

(lower quartile, upper quartile)Median prescribed KT/V

Table 11.2.7 (e): Proportion of patients with prescribed Kt/V ≥ 1.3, 1997-2012

YearNumber of

centersMin

5th Centile

LQ Median UQ95th Centile

Max

1997 44 32 42 50 60 69 80 911998 45 0 42 57 67 73 83 881999 67 29 45 65 73 84 94 1002000 99 26 43 64 79 84 94 1002001 114 33 42 67 75 84 93 1002002 132 26 43 65 74.5 83 92 982003 150 30 48 71 81 89 96 1002004 181 28 58 74 83 91 98 1002005 224 32 58 73 82 90.5 98 1002006 281 0 46 68 80 88 96 1002007 302 21 50 67 80 89 96 1002008 353 14 48 69 83 90 98 1002009 400 26 53.5 75 85 92 97.5 1002010 434 6 50 74 85 91 100 1002011 500 15 57 76 86 93 100 1002012 555 29 58 77 86 93 100 100


Figure 11.2.7 (e): Variation in proportion of patients with prescribed Kt/V ≥ 1.3 among HD centres 2012


0

10

20

30

40

50

60

70

80

90

100

% p

atie

nts

0 50 100 150 200 250 300 350 400 450 500 550Centre

(lower 95% CI, upper 95% CI)% with prescribed KT/V >=1.3

Table 11.2.7 (f): Median delivered Kt/V in HD patients, HD centres 2006-2012


2006 142 1 1.2 1.3 1.4 1.5 1.6 1.7

2007 157 1.1 1.2 1.3 1.4 1.5 1.7 1.8

2008 199 1 1.2 1.3 1.4 1.5 1.7 1.8

2009 239 1 1.2 1.3 1.4 1.5 1.6 2

2010 253 0.8 1.1 1.3 1.4 1.5 1.6 2

2011 302 0.9 1.2 1.3 1.4 1.5 1.7 2

2012 355 1 1.2 1.3 1.5 1.5 1.7 2.2


Figure 11.2.7 (f): Variation in median delivered Kt/V in HD patients among HD centres 2012


.6

.8

1

1.2

1.4

1.6

1.8

2

2.2

2.4

KT

/V

0 30 60 90 120 150 180 210 240 270 300 330 360Centre

(lower quartile, upper quartile)Median delivered KT/V

Table 11.2.7 (g): Proportion of patients with delivered Kt/V ≥ 1.2, HD centres 2006-2012


2006 142 0 43 65 76.5 86 94 100

2007 157 34 46 70 79 89 98 100

2008 199 21 49 68 81 89 100 100

2009 239 18 51 74 84 90 97 100

2010 253 0 47 71 83 89 98 100

2011 302 6 51 73 84 91 100 100

2012 355 26 49 74 85 92 98 100


Figure 11.2.7 (g): Variation in proportion of patients with delivered Kt/V ≥ 1.2, HD centres 2012


0

10

20

30

40

50

60

70

80

90

100

% p

atie

nts

0 30 60 90 120 150 180 210 240 270 300 330 360Centre

(lower 95% CI, upper 95% CI)% with delivered KT/V >=1.2

Table 11.2.7 (h): Median URR among HD patients, HD centres 2006-2012


2006 214 55.4 64.2 68.9 71.5 74.3 78.2 94.4

2007 245 56.1 65.3 69.6 71.8 74.8 78 95.5

2008 310 40.4 63.5 68.5 71.6 74.4 77.9 93.6

2009 350 60 64.4 68.7 71.8 74.1 77 93.3

2010 397 54.6 64.8 69 71.3 73.8 76.7 94

2011 464 45.2 64.6 68.8 71.7 74.3 77.9 96.8

2012 525 56.3 65.1 68.6 71.7 74 77.5 96


Figure 11.2.7 (h): Variation in median URR among HD patients, HD centres 2012


40

50

60

70

80

90

100

UR

R %

0 50 100 150 200 250 300 350 400 450 500Centre

(lower quartile, upper quartile)Median URR

Table 11.2.7 (i): Proportion of HD patients with URR ≥ 65%, HD centres 2006-2012


2006 214 0 50 69 79.5 88 97 100

2007 245 15 51 71 82 89 97 100

2008 310 0 43 69 82.5 90 98 100

2009 350 22 45 69 81 89 97 100

2010 397 13 48 69 82 90 98 100

2011 464 0 49 69 82 90 100 100

2012 526 17 50 68 80 89 98 100


Figure 11.2.7 (i): Variation in proportion of patients with URR ≥ 65% among HD centres 2012


0

10

20

30

40

50

60

70

80

90

100

% p

atie

nts

0 50 100 150 200 250 300 350 400 450 500Centre

(lower 95% CI, upper 95% CI)% with URR >=65%

Table 11.3.1(a): Unadjusted technique survival by year of entry, 1993-2012


Figure 11.3.1(a): Unadjusted technique survival by year of entry, 1993-2012


Yr 2012

Yr 2010

Yr 2008

Yr 2006

Yr 2004

Yr 2002

Yr 2000Yr 1998

Yr 1996Yr 1994

0.00

0.25

0.50

0.75

1.00C

umu

lativ

e su

rviv

al

0 24 48 72 96 120 144 168 192 216 240Duration in months

Kaplan-Meier survival estimates, by Year

Table 11.3.1(b): Unadjusted technique survival by year of entry (censored for death & transplant), 1993-2012


Figure 11.3.1(b): Unadjusted technique survival by year of entry (censored for death & transplant), 1997-2012


Yr '12 Yr '10 Yr '08 Yr '06 Yr '04 Yr '02 Yr '00 Yr '98 Yr '96 Yr '94

0.00

0.25

0.50

0.75

1.00

Cum

ulat

ive

surv

ival


Kaplan-Meier survival estimates, by Year

Table 11.3.2(a): Unadjusted technique survival by age, 1993-2012


Figure 11.3.2(a): Unadjusted technique survival by age, 1997-2012


Age>=65

Age 55-64

Age 45-54

Age 35-44

Age 25-34Age 15-24

Age 1-14

0.00

0.25

0.50

0.75

1.00

Cum

ulat

ive

surv

ival


Kaplan-Meier survival estimates, by Age

Table 11.3.2(b): Unadjusted technique survival by age (censored for death & transplant), 1993-2012


Figure 11.3.2(b): Unadjusted technique survival by age (censored for death & transplant), 1997-2012


Age>=65Age 55-64Age 45-54Age 35-44Age 25-34Age 15-24Age 1-14

0.00

0.25

0.50

0.75

1.00

Cum

ulat

ive

surv

ival


Kaplan-Meier survival estimates, by Age

Table 11.3.3(a): Unadjusted technique survival by diabetes status, 1993-2012

Diabetes statusInterval (month)

Non-Diabetic Diabetic

n % Survival SE n % Survival SE

0 23246 100 27980 1006 20715 94 0 24566 93 012 18551 90 0 21160 86 024 14966 83 0 15567 73 036 12264 77 0 11343 62 048 10037 72 0 8032 52 060 8174 66 0 5649 44 072 6639 61 0 3859 36 084 5330 56 0 2501 29 096 4284 52 0 1623 24 0108 3417 48 0 1010 19 0120 2712 44 0 640 15 0


Figure 11.3.3(a): Unadjusted technique survival by diabetes status, 1993-2012


Diabetic

Non-diabetic

0.00

0.25

0.50

0.75

1.00

Cum

ulat

ive

surv

ival


Kaplan-Meier survival estimates, by Diabetes

Table 11.3.3(b): Unadjusted technique survival by diabetes status (censored for death & transplant), 1993-2012

Diabetes statusInterval (month)

Non-Diabetic Diabetic

n % Survival SE n % Survival SE

0 23246 100 27980 1006 20715 99 0 24566 100 012 18551 99 0 21160 99 024 14966 99 0 15567 99 036 12264 98 0 11343 98 048 10037 98 0 8032 97 060 8174 97 0 5649 97 072 6639 97 0 3859 96 084 5330 97 0 2501 96 096 4284 96 0 1623 96 0108 3417 96 0 1010 95 0120 2712 95 0 640 94 0


Figure 11.3.3(b): Unadjusted technique survival by diabetes status (censored for death & transplant),

1993-2012


Diabetic

Non-diabetic

0.00

0.25

0.50

0.75

1.00

Cum

ula

tive

surv

ival


Kaplan-Meier survival estimates, by Diabetes

CHAPTER 11 Haemodialysis Practices

Documents

Transcript of CHAPTER 11 Haemodialysis Practices